Choreo LLC Has $1.78 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Choreo LLC raised its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 61.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,537 shares of the company’s stock after acquiring an additional 7,780 shares during the quarter. Choreo LLC’s holdings in HealthEquity were worth $1,779,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in HQY. Prudential PLC purchased a new position in HealthEquity during the second quarter valued at approximately $2,429,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of HealthEquity during the 2nd quarter valued at $146,000. Candriam S.C.A. acquired a new position in shares of HealthEquity in the second quarter worth $240,000. Arizona State Retirement System increased its stake in shares of HealthEquity by 2.3% in the second quarter. Arizona State Retirement System now owns 24,120 shares of the company’s stock worth $2,079,000 after acquiring an additional 540 shares during the last quarter. Finally, Chase Investment Counsel Corp raised its holdings in shares of HealthEquity by 19.0% during the second quarter. Chase Investment Counsel Corp now owns 40,956 shares of the company’s stock worth $3,214,000 after acquiring an additional 6,542 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Up 0.6 %

HealthEquity stock opened at $75.15 on Thursday. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. HealthEquity, Inc. has a fifty-two week low of $61.81 and a fifty-two week high of $88.26. The firm has a fifty day moving average price of $76.60 and a two-hundred day moving average price of $79.56. The firm has a market cap of $6.56 billion, a price-to-earnings ratio of 81.68, a P/E/G ratio of 1.22 and a beta of 0.52.

Insider Transactions at HealthEquity

In related news, Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the completion of the sale, the insider now owns 89,769 shares in the company, valued at approximately $7,168,952.34. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the completion of the transaction, the insider now directly owns 89,769 shares in the company, valued at approximately $7,168,952.34. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Frank Corvino sold 7,705 shares of the stock in a transaction on Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the completion of the sale, the director now directly owns 6,070 shares of the company’s stock, valued at $497,072.30. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 75,031 shares of company stock worth $6,103,625. Company insiders own 2.20% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on the company. Barrington Research restated an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Friday, August 30th. Robert W. Baird boosted their price target on HealthEquity from $98.00 to $104.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th. Bank of America cut their price objective on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, September 4th. Raymond James boosted their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. Finally, KeyCorp raised their price target on shares of HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a report on Wednesday, June 5th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $103.83.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.